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THE LANCET
The association of non-familial and late-onset AD and, to 
some extent also, of monozygous twinning with conditions 
related to non-optimal maturation and fertilisation of the 
oocyte, has been reported, ie, first and/or high birth order, 
very young and/or advanced maternal age, winter birth 
excess, specific constitutions (eg, reduced cognitive reserve 
capacity, proneness to aneuploid pregnancies). These 
environmental triggers may indicate that the quality of the 
oocyte at conception5 is related to monozygous twinning and 
future AD. They have to be separated from the genetic 
contribution in AD, particularly in non-familial and late- 
onset AD, as in many other constitutional diseases of 
so-called multifactorial or polygenic origin.
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«
S i r —We tried to corroborate in Danish registers1’2 the report 
by Raiha and colleagues (March 2, p 5 73)3 of a higher 
frequency of Alzheimer’s disease (AD) in individuals from 
monozygotic twin pairs, compared with individuals from 
dizygotic twin pairs. Furthermore, we compared die 
cognitive functions of elderly monozygotic and dizygotic 
twins using an interview-survey from 1995 among all Danish 
75+ year old twins. In this age group AD comprises more 
than half the dementia cases.'1
In our study all twins included were same-sexed and born 
before Feb 1, 1920. The Danish Hospital Discharge Register 
was established in 1977 and therefore only the 7144 twin 
individuals with known zygosity, who survived to 1977, were 
included. Of these 2690 survived to be eligible for the 1995 
interview survey. We have previously reported that mortality 
trajectories throughout adulthood are similar in monozygotic 
and dizygotic individuals.1 In the Danish register, dementia 
cases were sought under the same international classification 
of diseases (ICD) codes as in the Finnish study. The ICD 
group 290 consisted virtually only of “dementia senilis” 
diagnoses and it is therefore presented as one group in our 
table. Encephalopathy (ICD 781.79) was found only in six 
cases. Because we did not validate diagnoses through
Monozygotic Dizygotic
Hospital Discharge Register 1977-94:
Number of individuals 2546 4598
Mean age in 1977 (SD) 68-4(7-8) 67-9 (7-7)
Number hospitalised 1977-94 (%) 2168 (85-2) 3886 (84-5)
Number (%) with ICD-codes
290 (dementia senilis) 98 (3-8) 188 (4-1)
437 (diffuse cerebrovascular ischaemic disease) 90 (3*5) 160 (3-5)
Interview-survey 1995:
Number completing MMSE 550 1024
Mean age{SD) 80-0 (4-0) 80-2 (4-2)
MMSE-score
Number of individuals (%)
MMSE 26-30 330 (60-0) 635 (62-0)
MMSE 24-25 100 ( 18-2) 181(17-7)
MMSE 21-23 75 (13-6) 127 (12-4)
MMSE 18-20 29 (5-3) 50 (4-9)
MMSE <18 16 (2'9) 31 (3-0)
Table: Danish same~sex twins born before Feb 1 ,1920
976
medical records, we excluded the ICD  code 440.99 
(generalised arteriosclerosis), which was found to be the 
major source of misclassification in the Finnish study. The 
table shows the nearly identical hospitalisation pattern for 
monozygotic and dizygotic individuals.
In the interview-survey the proportion of responders, 
responders by proxy and non-responders was similar for 
monozygotic and dizygotic individuals (73:7:20 vs 74:6:20). 
Furthermore, the proportion where dementia was given as 
reason for proxy-interview or non-response was similar in 
monozygotic and dizygotic twins (4*9% vs 4-6%, p>0*5). In 
the table the mini mental state cognitive screening 
examination (MMSE) scores5 of those individuals who had 
physical impairments (which might affect their score) are 
excluded, together with those individuals who were reluctant 
to participate in the test. Inclusion of these individuals in the 
M M SE distribution also failed to show any significant 
difference in cognitive functions between monozygotic and 
dizygotic individuals.
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Human diploid-cell rabies vaccine: efficacy of 
four doses
Sir—R abies is a major health hazard and an economic 
burden for developing countries. Because of the cost of the 
human diploid-cell rabies vaccine (HDCV), Semple-type 
vaccines remain the usual treatment for patients bitten in 
these areas of the world. Unfortunately, neuroparalytic 
reactions are common with Semple-type vaccines,1 resulting 
in about 20% fatalities.
We compared serum rabies virus neutralising antibody 
(SRVNA) titres of 23 adults vaccinated following exposure 
to a rabid dogi none had received a rabies vaccine in die 
past 10 years. They were immunised with five, 1 mL 
intramuscular doses of H D C V  (Merieux Inactivated Rabies 
Vaccine, Pasteur Merieux Serums and Vaccines, Lyon, 
France), according to the recommendations of the World 
Health Organization.2 Blood samples were taken at 16 and 
45 days, after the fourth and fifth doses of the vaccine. 
SRVNA titres of double-blind coded sera were determined 
by the rapid fluorescent focus inhibition test.3 Titres were 
adjusted to international unit/mL (IU/mL) with US 
Standard Human Immune Globulin R3 as a reference 
serum. Mean SRVNA titres after the fourth vaccination
SRVNA levels
Fourth doses Fifth doses
Subjects (n) 23 23
Mean (SD) 53 (36) 16(24)*
Median 60 7*5*
Range 15-120 3-75-120
*p<0>01.
Table: SRVNA (IU/mL) after fourth and fifth  doses of HDCV
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